| Financial Year |
March 31 2023 |
| Monetary Funds |
642,113,233.72 |
| Held-for-trading Financial Assets |
12,401,242.42 |
| Notes Receivable |
68,486,009.99 |
| Accounts Receivable |
857,782,870.27 |
| Advances to Suppliers |
487,730,993.91 |
| Other Receivables |
265,965,224.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
417,316,057.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
131,488,439.82 |
| Total Current Assets |
3,725,917,646.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,507,928.00 |
| Investment Properties |
478,747,661.66 |
| Fixed Assetes |
1,849,222,472.64 |
| Under-construction Projects |
167,718,266.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
695,547,255.02 |
| R&D expenses |
-- |
| Goodwill |
470,440,360.83 |
| Long-Term Deferred and Prepaid Expenses |
22,968,820.22 |
| Deferred Income Tax Assets |
73,450,778.94 |
| Other Non-Current Assets |
7,840,000.00 |
| Sub-Total of Non-Current Assets |
3,813,731,108.98 |
| Total Assets |
7,539,648,755.05 |
| Short-Term Loans |
1,732,973,240.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
404,896,323.20 |
| Accounts Payable |
385,464,058.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,504,891.32 |
| Taxes Payable |
19,885,071.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
99,518,670.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
754,361,782.94 |
| Other Current Liabilities |
3,970,217.69 |
| Sub-Total of Current Liabilities |
3,664,738,242.63 |
| Long-term Loans |
1,158,570,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
254,887,885.73 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,620,181.61 |
| Deferred Income Tax Liabilities |
14,536,698.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,749,273,846.44 |
| Total Liabilities |
5,414,012,089.07 |
| Paid-In Capital(Or Share Stock) |
562,368,594.00 |
| Capital Surplus |
1,343,941,955.80 |
| Surplus Reserve |
84,570,074.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-172,586,769.42 |
| Minority Stockholder's Interest |
304,738,925.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,820,897,740.70 |
| Owner's Equity（Stockholder's Equity） |
2,125,636,665.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,539,648,755.05 |
